Investor Relations


2019 BIO International Convention - Immuno-Oncology
Thursday, June 6, 2019
10:30am - 12:00pm EDT

Helen Sabzevari, PhD, President of Precigen, Inc., a wholly-owned subsidiary of Intrexon and a clinical stage biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, will participate in the panel “Immuno-Oncology: Taking Immunotherapies to the Next Level” on June 6th from 10:30 am-12:00 pm ET. The presentation will not be webcast.